Log In
Contact Us

Expand Your Expertise with 2024 Annual Conference Recorded Sessions

Access curated conference session bundles featuring expert-led discussions—on demand and at your convenience.
PRIM&R’s conference education bundles offer a curated selection of recorded sessions, providing you with targeted learning opportunities. These on-demand bundles cover key topics such as IRB Review and Informed Consent, HRPP/IRB/IACUC management; social, behavioral, and educational research; and emerging research challenges. Designed for flexibility, each bundle features expert-led sessions that deliver in-depth insights into critical issues in research oversight.

Human Subjects Review Annual Conference Bundle

PRIM&R’s Human Subjects Research sessions provide in-depth discussions on ethical, regulatory, and practical challenges in IRB administration and oversight. Led by experts, these sessions cover key topics such as informed consent, risk assessment, regulatory compliance, and evolving policies to ensure the protection of research participants.
  • IRB Review and Informed Consent
  • HRPP/IRB Management
  • Social, Behavioral, and Educational Research
  • Emerging Research Challenges
  • Research Involving Data and New Technologies
  • Pharma/Biotech Perspectives
  • Education and Training

IRB Review and Informed Consent

This comprehensive recording package combines two critical tracks for HRPP/IRB professionals seeking to enhance their knowledge and skills. The IRB Review track offers best practices for both new and experienced IRB reviewers, covering key topics such as the roles and responsibilities of IRB chairs and members, common review challenges, and innovative strategies to address those issues effectively. The Informed Consent track dives deep into considerations and best practices of the consent form and process. These sessions provide essential guidance on navigating the ethical complexities of reviewing and obtaining consent in today’s evolving research landscape. Together, these tracks equip your team with the expertise needed to ensure thorough, ethical reviews and consent practices.

50 Sessions Included in Bundle

  • A01 - PLENARY: Reimagining Informed Consent Processes to Support Informed, Values-Concordant Decisions
  • A02 - How Do You Actually Review a Protocol Involving Artificial Intelligence (AI)?
  • A03 - Why “It Depends”: General Considerations for IRBs and HRPPs When Reviewing Research Using FDA-Regulated Products
  • A06 - Great “Private” Expectations: What Is Publicly Available Private Information?
  • A08 - What is the Role of Regret and Apology in Protecting the Human Participants of Clinical Trials?
  • A16 - PLENARY: PI Responsibility & Accountability Versus Effectiveness of Institutional Compliance and Ethics Review: What Will Really Make a Difference in How We Conduct Research?
  • B01 - PLENARY: Ethical Considerations With Healthy Research Participants: Current Perspectives From the Field
  • B03 - Assessing Capacity to Consent for Research Participation: When and How Do You Actually Do It?
  • B04 - Ethical Implications and Practical Application of Broad Consent
  • B09 - When SBER Meets the Definition of a Clinical Trial, Then What?
  • B10 - Advancing Justice, Equity, and Trustworthiness Through Community Engaged Research (CEnR): What HRPPs/IRBs Need to Know
  • C04 - What's That You're Wearing? Human Research Protections and Wearable Devices
  • C05 - IRBs Greatest Challenges for Youth-Centered Research
  • C06 - Medical Devices: A Beginner's Guide to Understanding the Basics of FDA Regulation and How to Apply it to a Study
  • C07 - This Coffee Is HOT! Burning Topics in the SBER Space (Needle) C08 - Help! I Don't Understand: Making the Consent Process and Form Meaningful Through Health Literacy and Adult Learning Theory
C18 - Committee Meeting Navigation for Those in the RoomD01 - PLENARY: Responsibility Does Not End With Death: Establishing Systems for Ethical Decedent ResearchD04 - Relationship Building to Respect Tribal Sovereignty and Improve Research SafetyD06 - The Limits of Permissible Research Without ConsentD07 - Reviewing Incidents of Non-Compliance: Strategies for IRB Chairs and MembersD09 - The Shifting Paradigm of Data Sharing: Navigating New Challenges Through a Participant-Centered LensD10 - Accessibility Basics: Making Word Documents AccessibleE03 - All Things Subpart CE04 - Building Trust in Science: Enabling Frameworks for Returning Individual Research Results to Research ParticipantsE07 - Using Artificial Intelligence (AI) to Author Key Information (KI) Sections of Human Research Consent DocumentsE08 - PLENARY: Responsible Research Practices in ComputingE09 - Robots in Disguise: When Your Participants are More Than Meets the EyeF01 - PLENARY: Risk Associated With Human Subjects Research: Whom Are We Obligated to Protect?F02 - PLENARY: Artificial Intelligence (AI) Days of Future's Past: Tomorrow's Research Yesterday F03 - Key Information in Informed Consent: Ethical Principles, Policy, and PracticeF04 - IRB Review of Research Involving Politicized Topics and Populations F08 - Navigating Ethical and Institutional Considerations for Data and Biospecimen Sharing in the Era of Single (sIRB)F09 - I Don't Remember This Being in the Training Manual: An Exploration of Challenging IRB Situations
F17 - Trust Me, I Know What I'm DoingF18 - Shake It Up: An Interactive Discussion of Lessons Learned from IRB/IACUC LeadersG01 - Are the Ways We Contemplate Risk Outdated?G02 - Change the Game By Working Together: Tips for Increasing HRPP/IRB and Researcher CollaborationG04 - Expectations for the Use of Electronic Systems to Conduct Clinical Trial Activities and Considerations for IRBs: Perspectives From Regulators and Institutional Review BoardsG07 - Exploring the Enigma of the Expedited (Category 7)G08 - Let It Go! Strategies to Prevent Over-Regulation During Local Context ReviewG13 - PLENARY: Ethical Review of Human and Animal Subjects Research ProposalsG15 - Building Bridges: Towards an International Framework for Specimen Sharing (Part II)H01 - PLENARY: Regulatory and IRB Challenges in Reviewing Decentralized Clinical Trials (DCTs)H02 - Group Harm: A Toolkit for Researchers, IRBs, and Data Access CommitteesH04 - Comparative Effectiveness Research (CER): When Important Research Does Not Fit the Regulatory MoldH06 - What Are You Going To Do With My Specimens and Data? When Research Specimens and Data are Used for Commercial ProfitH09 - Exempt Study Review: How to Find Flexibilities in the Current RegulationsH13 - Tick-Tock! How to Not Waste Your Time While Writing Minutes!Opening General Session: More Cure, Less Side Effects: A Potential Role for Preclinical Studies

Cost

Members: $100 Nonmembers: $310
Purchase

HRPP/IRB Management and Administration

This conference recording package offers content from two essential tracks designed to elevate the knowledge and effectiveness of HRPP/IRB professionals. The Education and Training track focuses on developing robust educational programs that equip your team with understanding ethical principles, professional standards, and the latest guidance and regulations. This track provides practical examples, varied educational approaches, and helpful resources to build strong training foundations. The HRPP/IRB Management and Administration track goes beyond everyday operations, addressing complex challenges HRPP/IRB professionals face.
With this track, you will gain access to expert-led discussions on innovative solutions, practical tools, and proven strategies to handle tough issues in your office or committee.
Whether you are refining training programs or tackling operational hurdles, this package delivers the insights and actionable takeaways your team needs to thrive in a dynamic research environment.

50 Sessions Included in Bundle

  • A04 - Advancing Gender Inclusivity in Research: Overcoming Political and Regulatory Challenges in Participant Materials
  • A08 - What is the Role of Regret and Apology in Protecting the Human Participants of Clinical Trials?
  • A09 - Shift Your Focus: Transforming an HRPP Into a Collegial and Efficient Partner of the Research Community
  • A10 - Decentralized Clinical Trials (DCTs) and the Community Dimension: Advantages and Challenges
  • A17 - Consciously Uncoupling? When Institutions and Investigators Separate (amicably, or sometimes not so much)
  • A18 - The Cost to Having a Revolving Door: PI Onboarding & Exit Planning
  • A20 - How Institutional Leaders Can Promote COI Program Effectiveness
  • B06 - Evaluating the Impact of Current and Future Single IRB (sIRB) Requirements on Local IRBs
  • B07 - A Crisis Is a Crisis: Lessons Learned From Human-Based and Animal-Based Controversies and What We Can Learn From Our Colleagues Across the Hall
  • B17 - Effectively Managing the Use of Controlled Substances in Research
  • B18 - Cross Training and Successful Transfer of Knowledge
  • B19 - PLENARY: Institutional Approaches to Research Security Programs
  • C07 - This Coffee Is HOT! Burning Topics in the SBER Space (Needle)
  • C09 - From Researcher to Sponsor Investigator: How to Work With Your Broader HRPP to Develop and Deploy Safe, Effective, and Ethical Artificial Intelligence (AI)
  • C17 - Nurturing True Inclusion: Moving Beyond Tokenism to Actual Inclusion
  • C19 - What You Don't Know Can Hurt You: Using Metrics to Evaluate Research Administrative Activities
C20 - PLENARY: Research Integrity Management in the New Public ArenaD02 - When the Feds Come to Town: What to Expect from a Federal Site Visit or InspectionD08 - The Island of Misfit Rules: How Not-So Day-to-Day Issues Can Ruin Your DayD10 - Accessibility Basics: Making Word Documents AccessibleD18 - Hiring , Diversity and Soft Skills: How Do We "Walk the Talk" and Get What We Need/Want From New Hires?D19 - Do Institutional Officials (IOs) Understand Ethics?D20 - Retaining Good Research Ethics and Oversight StaffE04 - Building Trust in Science: Enabling Frameworks for Returning Individual Research Results to Research ParticipantsE10 - The Essentials of Onboarding and Training IRB AdministratorsE16 - Done Wrong, Gotta Pay: Research Non-compliance and Research Misconduct and Possible Sponsor Pay-BackE19 - Balancing Risk and Reward in Research ProgramsF01 - PLENARY: Risk Associated With Human Subjects Research: Whom Are We Obligated to Protect?F02 - PLENARY: Artificial Intelligence (AI) Days of Future's Past: Tomorrow's Research YesterdayF06 - Human Subjects Research Determinations: Before and After the FactF07 - Adults with Developmental Disabilities and Research: Ethical, Legal, and Social Implications (ELSI) Solutions to Inclusion as Co-Researchers and Research ParticipantsF09 - I Don't Remember This Being in the Training Manual: An Exploration of Challenging IRB Situations F10 - Designing an HRPP/IRB Website that Builds TrustF16 - Plenary: Conducting Research "With" and "Not On" Indigenous PopulationsF17 - Trust Me, I Know What I'm Doing

F19 - Proposed Changes to the Public Health Policy (PHS) on Research Misconduct: Impact on the Researcher CommunityF20 - Developing an Emergency Preparedness Plan for an Effective Research System G01 - Are the Ways We Contemplate Risk Outdated?G02 - Change the Game By Working Together: Tips for Increasing HRPP/IRB and Researcher CollaborationG04 - Expectations for the Use of Electronic Systems to Conduct Clinical Trial Activities and Considerations for IRBs: Perspectives From Regulators and Institutional Review BoardsG06 - Managing Dual/Multiple Relationships: Grappling With Identity and Interpersonal Boundaries in Human Subjects ResearchG07 - Exploring the Enigma of the Expedited (Category 7)G09 - IBC and IRB Collaboration: Working Together for Safety and OversightG13 - PLENARY: Ethical Review of Human and Animal Subjects Research ProposalsGeneral Session: 50 Years of PRIM&R: Pioneers, the Present, and the Path ForwardH01 - PLENARY: Regulatory and IRB Challenges in Reviewing Decentralized Clinical Trials (DCTs)H09 - Exempt Study Review: How to Find Flexibilities in the Current RegulationsH13 - Tick-Tock! How to Not Waste Your Time While Writing Minutes!H14 - Don't Reinvent the Wheel! How to Ask the Right Questions and Leverage Existing Resources to Address Critical Compliance NeedsH15 - Considering Yourself: Self‐Care for Compliance Professionals

Cost

Members: $100 Nonmembers: $310
Purchase

Social, Behavioral, and Educational Research

With this package, you will gain a deeper understanding of the unique challenges and considerations in the conduct and review of Social, Behavioral, and Educational Research (SBER). Whether you're new to SBER or looking to enhance your expertise, this track covers both basic and advanced topics relevant to the ethical oversight and review of research in these fields.

18 Sessions Included in Bundle

  • A06 - Great “Private” Expectations: What Is Publicly Available Private Information?
  • B03 - Assessing Capacity to Consent for Research Participation: When and How Do You Actually Do It?
  • B09 - When SBER Meets the Definition of a Clinical Trial, Then What?
  • B10 - Advancing Justice, Equity, and Trustworthiness Through Community Engaged Research (CEnR): What HRPPs/IRBs Need to Know
  • C04 - What's That You're Wearing? Human Research Protections and Wearable Devices
  • C05 - IRBs Greatest Challenges for Youth-Centered Research
  • C08 - Help! I Don't Understand: Making the Consent Process and Form Meaningful Through Health Literacy and Adult Learning Theory
  • D04 - Relationship Building to Respect Tribal Sovereignty and Improve Research Safety
  • D08 - The Island of Misfit Rules: How Not-So Day-to-Day Issues Can Ruin Your Day
D10 - Accessibility Basics: Making Word Documents AccessibleE03 - All Things Subpart CE09 - Robots in Disguise: When Your Participants are More Than Meets the EyeF02 - PLENARY: Artificial Intelligence (AI) Days of Future's Past: Tomorrow's Research Yesterday F04 - IRB Review of Research Involving Politicized Topics and PopulationsF06 - Human Subjects Research Determinations: Before and After the FactF09 - I Don't Remember This Being in the Training Manual: An Exploration of Challenging IRB SituationsG02 - Change the Game By Working Together: Tips for Increasing HRPP/IRB and Researcher CollaborationH02 - Group Harm: A Toolkit for Researchers, IRBs, and Data Access Committees

Cost

Member: $36 Nonmember: $130
Purchase

Emerging Research Challenges

Stay at the forefront of research oversight with this comprehensive recording package, covering three dynamic and essential tracks. The Emerging Research Challenges and Breaking Issues track tackles the latest challenges in research ethics and oversight, including the complexities of new technologies, novel study designs, and domains of research that don’t fit within traditional human research frameworks. Coupled with the Research Involving Data and New Technologies track, which explores the regulatory and ethical considerations surrounding the use of data, biospecimens, and emerging technologies, this package offers critical insights into managing consent, data sharing, and participant engagement.
Finally, the Pharma/Biotech Perspectives track brings together professionals from the pharmaceutical, device, and biotechnology industries to discuss mutual challenges in global research and development, complex trial designs, gene therapy programs, and more.
Together, these tracks provide the knowledge and strategies necessary to navigate the rapidly evolving research landscape.

30 Sessions Included in Bundle

  • A02 - How Do You Actually Review a Protocol Involving Artificial Intelligence (AI)?
  • A03 - Why “It Depends”: General Considerations for IRBs and HRPPs When Reviewing Research Using FDA-Regulated Products
  • A05 - The Ethical Conduct of Cell and Gene Therapy Research: Novel Challenges for Industry and the IRB
  • A06 - Great “Private” Expectations: What Is Publicly Available Private Information?
  • A08 - What is the Role of Regret and Apology in Protecting the Human Participants of Clinical Trials?
  • B02 - Cybersecurity and Research Integrity: Can We Be Trusted to Keep Research Information Safe?
  • B04 - Ethical Implications and Practical Application of Broad Consent
  • B17 - Effectively Managing the Use of Controlled Substances in Research
  • C04 - What's That You're Wearing? Human Research Protections and Wearable Devices
  • C09 - From Researcher to Sponsor Investigator: How to Work With Your Broader HRPP to Develop and Deploy Safe, Effective, and Ethical Artificial Intelligence (AI)
  • C10 - Updates to the Declaration of Helsinki
  • C16 - PLENARY: Bridging Preclinical to Clinical Research With Artificial Intelligence (AI) and Digital Biomarkers: Current Landscape, Vision, and the Collaborative Path Toward Improved Translation
D01 - PLENARY: Responsibility Does Not End With Death: Establishing Systems for Ethical Decedent ResearchD09 - The Shifting Paradigm of Data Sharing: Navigating New Challenges Through a Participant-Centered LensE04 - Building Trust in Science: Enabling Frameworks for Returning Individual Research Results to Research ParticipantsE07 - Using Artificial Intelligence (AI) to Author Key Information (KI) Sections of Human Research Consent DocumentsE08 - PLENARY: Responsible Research Practices in ComputingE09 - Robots in Disguise: When Your Participants are More Than Meets the EyeF01 - PLENARY: Risk Associated With Human Subjects Research: Whom Are We Obligated to Protect? F02 - PLENARY: Artificial Intelligence (AI) Days of Future's Past: Tomorrow's Research Yesterday F04 - IRB Review of Research Involving Politicized Topics and Populations F08 - Navigating Ethical and Institutional Considerations for Data and Biospecimen Sharing in the Era of Single (sIRB) G01 - Are the Ways We Contemplate Risk Outdated? G06 - Managing Dual/Multiple Relationships: Grappling With Identity and Interpersonal Boundaries in Human Subjects ResearchG15 - Building Bridges: Towards an International Framework for Specimen Sharing (Part II)H04 - Comparative Effectiveness Research (CER): When Important Research Does Not Fit the Regulatory Mold
H05 - Pharma Perspectives on the Use of Social Media and Social Media Influencers in Clinical ResearchH06 - What Are You Going To Do With My Specimens and Data? When Research Specimens and Data are Used for Commercial ProfitOpening General Session: More Cure, Less Side Effects: A Potential Role for Preclinical StudiesOpening Session: The Next Frontier: Space Exploration Research

Cost

Member: $60 Nonmember: $190
Purchase